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Abstract 
Recent research are directing the diagnostic methods for periodontitis disease so 
that the activity can be identified by quantifying biomarkers found in samples of 
gingival crevicular fluid, serum and saliva. 
Periodontitis is an inflammatory disease that affects the connective tissue 
insertion and the supporting bone around the tooth. The triggering of the disease 
stimulates the production of inflammatory proteins which can be reflected in the saliva. 
Saliva is a physiological fluid that is produced by salivary glands. It has a 
complex composition containing locally secreted proteins, as well as molecules of the 
systemic circulation. These characteristics make it a potentially good candidate to 
identify biomarkers that reflect changes resulting from periodontitis and other systemic 
diseases. 
Due to that, this review article aims to compile the existing knowledge in this 
area, based on relevant literature about this subject and to analyze the advances that 
have been made in the field, and to clarify if the biomarkers present in saliva constitute 
a valid alternative in the diagnosis. 
Resumo 
Pesquisas recentes estão a direccionar os métodos de diagnóstico da Periodontite 
para que a actividade da doença possa ser identificada através da quantificação de 
biomarcadores encontrados em amostras de fluido crevicular gengival, soro e salíva. 
A periodontite é uma doença inflamatória que afeta o tecido conjuntivo de 
inserção e o osso de suporte a volta do dente. O desencadear desta doença estimula a 
produção de proteínas inflamatórias que pode ser reflectida na saliva. 
A saliva é um fluido fisiológico, produzido nas glândulas salivares. Tem uma 
composição complexa, contendo proteínas secretadas localmente, bem como moléculas 
de circulação sistémica. Estas características fazem com que seja um potencialmente 
bom candidato para identificar biomarcadores que reflitam alterações decorrentes da 
periodontite e de outras doenças bocais e sistémicas. 
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Deste modo, este artigo de revisão tem como objetivo compilar o conhecimento 
existente nesta área, baseado em literatura relevante sobre este tema  dando a conhecer 
os avanços que têm sido feitos assim como esclarecer se atualmente os biomarcadores 
presentes na saliva constituem uma alternativa válida no diagnóstico.
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Introduction 
Peridontal disease is the leading cause of tooth loss in adults1 Periodontitis is an 
inflammatory condition initiated by the pathogenic bacterial biofilm of the tooth 
supporting tissues2. Nevertheless,  it is the activation and mediation of host 
inflammatory responses that are ultimately responsible for the destructive events 
occurring in the periodontum. Infact, studies of the host immune response to pathogenic 
bacteria have contributed to the present understanding of the pathogenesis of 
periodontal diseases3 4 5. 
Periodontal pathogens activate host cells to produce proinflammatory mediators 
and enzymes, which in turn promote the destruction of periodontal tissues. Stimulation 
of epithelial cells, neutrophils, macro phages, and lymphocytes, with microbial 
components, increases cellular secretion of inflammatory cytokines, such as interleukin-
1β (IL-1β), interleukin-6 (IL-6), and tumor necrosis factor-a (TNF-α) . Also, the release 
of lysosomal and cytoplasmic enzymes, like for example, neutrophil-based elastase, 
myeloperoxidase, matrix metalloproteinases (MMPs), and lactate dehydrogenase 
(LDH), into periodontal tissues is higher in the areas with inflammation67 8. 
Diagnostic methods used in clinical practice today lack the ability to detect the 
onset of inflammation and to identify those patients who are susceptible to future 
disease progression9. 
In fact the traditional diagnosis of periodontitis is based on clinical and 
radiographic assessments of periodontal tissues . Clinical parameters are employed such 
as probing depth (PD), bleeding on probing (BP), clinical attachment levels (CAL) , 
plaque index (PI), and radiographic loss of alveolar bone 10 
However, the most desirable goal in health care promotion, and delivery would 
be to monitor the periodontal health status and the onset, progression, and treatment 
outcome of periodontal diseases through non-invasive means. 
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As an easily collected and non-invasive specimen, saliva has been used as a 
diagnostic fluid in medicine 11 12 
In this context, it appears as a potentially useful diagnostic tool due to its easy 
collection and presence of locally-derived and systematically-derived markers of 
periodontal disease4  5 
For periodontal disease assessment, most of the research has focused primarily 
on gingival crevicular fluid (GCF) biomarkers that provide local disease status, but it 
represents a difficult approach to use for clinical applications 13 14. Although GCF is 
considered as the main source of periodontitis-associated cytokines and host- derived 
enzymes , these agents will eventually pass to saliva, which, unlike GCF, appears as an 
easy and non-invasive collectible specimen for periodontal disease detection . The 
major aim in the research of salivary diagnosis of periodontal disease is  to find 
marker(s) that could be used, preferably as chair-side tests, for example, to determine 
the extent of periodontitis or the results of periodontal treatment, or even to a lesser 
extent to detect periodontitis in field studies .15 
Within this context, this review aims to compile the existing knowledge in this 
area, describing the progress that has been done and analyzing if biomarkers present in 
saliva constitute a potentially valid alternative in periodontal  disease diagnosis.
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Material and methods 
To carry out this review, it was made a research on  the topic "salivary proteins 
as biomarkers for periodontal disease". The articles used were published between 2005-
2012 in EBSCO Host databases (CINAHL, Pre-CINAHL, MEDLINE, BIOMED, 
PUBMED) and B-ON (Academic search premier Elsevier, Springer Link and Wiley 
intercience) as well as in journals printed on paper, available in the FMDUP library, 
using the combination of the following keywords: Periodontitis, Saliva, Biomarkers, 
inflammation mediators, diagnosis. 
This search retrieved about 160 articles of which 67 articles were used. The 
exclusion criteria were: 
- Scientific articles published before 2005 
- Articles with incomplete abstract or full text not available
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Pathogenesis  of periodontal disease  
Subgingival bacterial biofilm (plaque) initiates gingival inflammation 
(gingivitis). The first bacteria that form a biofilm on cleaned tooth surfaces are from the 
Streptococci species (gram-positive cocci). Thus supragengival plaq ue is firstly 
formed by a colonization of gram-positive organisms. Within two days gram-negative 
bacteria also appear in the subgingival biofilm and gingival inflammation begins 17. At 
this point, gram-negative organisms are no longer subjected to  normal oral hygiene 
procedures. Endotoxins (lipopolysaccharides present in the cell wall of gram-negative 
organisms released during cell death) are an important cause of gingival tissue damage 
caused by Gram negative bacteria in the subgingival biofilm1617. Endotoxins directly 
destroy gingival cells.  They enhance tissue destruction due to stimulation of the 
immune response associated with gingival inflammation. Tissue damage is promoted 
through cytotoxicity, complement activation, and bone resorption. 17 Bacteria first 
contact with immune system occurs in epithelium with Langerhams cells which process 
antigens1617. 
Bacterial products that contact gingival connective tissue initiates an acute 
inflammatory response leading to vasodilatation, edema and polymorphonuclear 
leukocyte (P.M.N) activation 16. One of the first effects of bacterial contact with gingival 
tissue is activation of mast cells. Mast cells have Toll like receptors which initiate  
production of vasoactive substances such as histamine which induce vascular 
permeability and vasodilatation17.  This vasodilatation and increased permeability of 
capillaries is associated with edema and diapedesis of leukocytes from the blood vessels 
into the connective tissue of the gingiva. Mast cells produce other inflammatory 
mediators such as Slow- Reacting Substance of Anaphylaxis, leukotriene C4,  Tumor 
Necrosis factor alpha (TNF-α).and IL-6. 17These activate the acute inflammatory 
response. Polymorphonuclear leukocytes (P.M.N.s) are the characteristic dominant 
inflammatory cells of acute inflammation of the gingival. PMNs are able to migrate 
through tissue towards chemotaxic substances such as peptides from bacteria, saliva, 
Endotoxin,IL8 and activated complement. PMNs are able to engulf bacteria by a 
process of phagocytosis.17 
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Monocytes become macrophages in inflamed gingival tissue. They produce 
cytokines such as IL-1 and TNF-α which have a wide inflammatory influence as well as 
stimulating osteoclasts proliferation, differentiation and activation 17. PGE2  another  
activator of inflammation and osteoclastogenisis, is also secreted in response to IL-
1,TNF-α and LPS.16 17 
As gingivitis develops the initial acute inflammatory response continues and a 
chronic inflammatory response is developed. Lymphocytes and capillary proliferation 
are two important factors that characterize this chronic inflammation17. 
Activation of complement is another part of the immune response seen in 
gingivitis 16. Activated T lymphocytes produce cytokines that enhance inflammation and 
can also cause damage to gingival and periodontal cells. Two important cytokines are 
iIL-1 and TNF-α. The combined acute and chronic inflammation observed in gingivitis 
and periodontitis is destructive to bacteria. However, it also causes damage to the 
connective tissue of gingival and the periodontal tissues 17. Another mechanism 
associated with the breakdown of connective tissue in periodontal disease involves 
matrix metalloproteinases (M.M.P). These are produced by PMNs, Macrophages 
,Fibroblasts and Epithelial cells 17. Cytokines such as IL-1β induce MMP production 
from fibroblasts, wich is inhibited by  TIMPs and α2 macroglobulin. This equilibrium 
that regulate the production of MMP can be changed by inflammation. 17 
Bone destruction is a consequence of osteoblastsic and/or inflammatory cells 
activation of osteoclast differentiation  via the production of cytokines such asM-CSF, 
RANKL, IL-1, TNF-α and Prostaglandins (PGE)17. Activated osteoclasts destroy the 
inorganic and organic bone components by the release of acid.and lytic enzimes, such as 
cathepsin k17. MMPs from osteoblasts will also destroy the organic collagenous 
components of the bone. 17 
Thus, the bacterial-induced inflammation on gingivitis can spread apically and 
involves the destruction of connective tissue of the periodontum, including bone17. This 
results in periodontal disease. The damaged epithelium of the gingival sulcus 
proliferates apically. Since loss of attachment of connective tissue fibers to cementum 
occurs, the pocket epithelium migrates to line the root surface17.
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Auxiliary exams in periodontitis diagnostic 
Clinical exams 
Probing depth - periodontal probing is the best diagnostic tool to gather 
information regarding the health status and attachment level of periodontal tissues. It 
serves multiple purposes: to assess the hemorrhagic response to physical pressure; to 
determine the presence of etiologic factors such as calculus, defective dental 
restorations, and root erosion; to locate the cement-enamel junction (CEJ); and to 
determine the pocket dimensions18. Periodontal probing has several drawbacks when 
used to monitor periodontal status longitudinally. Despite its lack of accuracy in 
determining sulcus or pocket depth, probing provides the clinician with a useful 
estimate of the location of the coronal insertion of intact connective-tissue fibers into 
the root18. 
Bleeding on probing - The bleeding on probing (BOP) is a widely used clinical 
sign as indicator of the periodontal condition and disease progression. BOP as predictor 
of future periodontal deterioration seems to significantly increase when associated with 
periodontal pocket depth greater than or equal to 6 mm19. 
Clinical attachment levels – Attachment levels are excellent indicators of past 
destruction of the periodontal attachment apparatus and can be used to monitor the 
progression of periodontitis20. Attachment level measurements are more frequently used 
as clinical end-points in clinical trials than by private practitioners to determine the 
periodontal status of patients and to monitor patient responses to periodontal therapy. 
Clinical attachment level measurements have been used in clinical trials to evaluate a 
systemic host modulatory agent, demonstrating their utility as surrogate markers of 
efficacy 20 
 Plaque index – The quantification of the amount and distribution of plaque on 
tooth surfaces, assesses the thickness of plaque at the cervical margin of the tooth 
(closest to the gum). Four areas, distal, facial or buccal, mesial, and lingual, are 
examined. Each tooth is dried and examined visually using a mirror, an explorer, and 
adequate light. The explorer is passed over the cervical third to test for the presence of 
plaque.21  
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Radiographic loss of alveolar bone – Radiographs are used to assess severity and 
pattern of bone loss, root length, anatomy and position, and to detect pathologic 
lesions22. Signs such as enlargement of the periodontal ligament space, absence of the 
lamina dura, bone defects (vertical and horizontal) and a diffusion image in the 
furcation area, associated with clinical signs, are suggestive of the presence of 
periodontal disease.22 . Radiographs taken from proximal sites suggestive of mild bone 
loss, can be used to control the progression of the defect years later 23. 
Laboratory exams 
Enzyme-Linked Immunoabsorbent Assay (ELISA) – The purpose of an 
ELISA assay is to determine if a particular antigen (usually a protein) is present in a 
sample and, if so, how much. ELISA separates some component of the analytical 
reaction mixture by adsorbing them onto a solid phase which is physically immobilized. 
In the ELISA assay a liquid sample is added onto a stationary solid phase with special 
binding properties. After some incubations and washes with multiple liquid reagents 
that are sequentially added, it occurs some optical change in the final solution in the 
well from which the quantity of the analyte is measured. For that, an enzyme reacts with 
the appropriate substrates wish elicits a change in the color of the solution occurs, which 
is used as a signal. However, the signal has to be associated with the presence of an 
antibody or antigen, which is why the enzyme has to be linked to an appropriate 
antibody24  
Time-resolved immunofluorometric assays (TR- IFMA) - The assay is based 
on a system that embodies a dry-reagent all-in-one immunoassay concept and utilizes a 
stable fluorescent lanthanide chelate as well as time-resolved fluorometry25.  TR-IFMA 
is characterized by lower detection limits and greater specificity, reproducibility and 
practicability25. Ultrasensitive immunoassay methods are developed and used in clinical 
diagnostics to measure extremely low concentrations of specific compounds in highly 
complex samples 25.
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Possible salivary biomarkers 
Inflammatory biomarkers 
Periodontal disease initiates with inflammation of the gingival apparatus and 
periodontal tissues in response to bacterial plaque accumulation. The persistent presence 
of the multispecies bacterial biofilm leads to chronic inflammation and an abundance of 
inflammatory molecules in oral fluids, that can be monitored and used as biomarkers for 
the disease. 
 
Interleukine-1β - ( IL-1β) - Interleukine-1β is a pro-inflammatory cytokine that 
induces widespread gene expression, including cyclo-oxygenase-2, inducible nitric ox-
ide synthetase, and metalloproteinases that can contribute to the activation of osteoclasts 
and, consequently, to the bone resorption.
26
  This cytokine is produced by activated 
macrophages as a proprotein, which is proteolytically processed to its active form by 
caspase 1 (CASP1/ICE). It is an important mediator of the inflammatory response, and 
is involved in a variety of cellular activities, including cell proliferation, differentiation, 
and apoptosis 27.  Of the two isoforms of IL-1 (i.e., IL-1α and IL-1β), IL-1β is more 
potent in stimulating bone resorption and is the more most frequently occurring form in 
periodontitis.
28
  It is produced during periodontal inflammation and tissue destruction29  
In the periodontum, IL-1β may be synthesized and secreted by the local connective tis-
sue cells (fibroblasts and endothelial cells), or by the infiltrating leukocytes In clinical 
studies, increased levels of IL-1β have been detected in GCF and have been associated 
with gingival inflammation, periodontal disease severity and an absence of therapeutic 
effectiveness.
30
 The levels of IL-1β also positively correlated with several periodontal 
indices parameters: bleeding on probing, clinical attachment level, percentage of sites 
with pocket depths of at least 4 mm and overall periodontal disease severity.
29
 
 
Interleukine-6 (IL-6)- IL-6 displays a range of functions, including acute-phase 
protein induction, B- and T-cell growth and differentiation, and plays a crucial role in 
osteoclast generation and activation. 
32
 IL-6 is produced by T and B cells, macrophages, 
endothelial cells, epithelial cells and fibroblasts in response to infection, stress and neo-
plasia. It is also released in response to IL-1 and TNF stimulation of many of these cell 
types
32 It is responsible for the transition from acute to chronic inflammation by modi-
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fying the present leukocyte infiltration (from polymorphonuclear neutrophil to mono-
cytes/macrophages) and by stimulating the T and B cells, favoring chronic inflammato-
ry response 31. Furthermore, it activate cellular differentiation of mesenchymal stem 
cells for the osteoblastic lineage, it is a potent anti-apoptotic agent in osteoblastic cells, 
being  therefore, responsible for bone resorption and inducing the production of metal-
loproteinasese  32. Costa et all e Ng PY et all showed in their studies that, IL-6 levels 
were directly proportional to bone loss scores of adult patients with chronic periodonti-
tis
29 33
.  Thus, IL-6 appears to be a useful indicator or marker for diagnosis of periodon-
titis 33. 
 
Tumor necrosis factor- α (TNF-α) – TNF- α is a proinflammatory and immu-
no-regulatory cytokine central to the pathogenesis of various inflammatory conditions 
34
. It plays a role in the recruitment of inflammatory cells and bone resorption through 
its ability to stimulate IL-1 and granulocyte macrophage colony-stimulating factor 
(GM-CSF) expression, to inhibit bone collagen synthesis, to induce collagenases ex-
pressions and by stimulating osteoclast differentiation in the presence of GM-CSF. Alt-
hough one report suggested that TNF-α was difficult to detect in saliva 39, others found 
low levels of TNF-α in that fluid 29 30. Frodge et all reported that TNF-α levels were 
detectable in all salivary samples from
3536
  patients, who had chronic adult periodontal 
disease and in healthy the controls 
36
. In addition, they found that TNF-α levels in saliva 
were significantly elevated (by two times) in periodontitis subjects compared with the 
controls. As it happens with IL-1β, elevated salivary TNF-α levels correlated with an 
increased number of sites with bleeding on probing, pocket depth sites of at least 4 mm 
and clinical attachment levels of at least 2 mm 
3.
 Similar findings have been reported by 
Ng et al
29
. These data suggests that salivary TNF-α levels may have utility for the 
screening diagnosis of chronic periodontitis in adults. 
 
Macrophage inflammatory protein (MIP)-1α - (MIP)-1α  is a member of the 
cysteine-cysteine  chemokine family, which is secreted by inflammatory cells and is 
primarily associated with cell adhesion and migration
37
. It stimulates monocytes and/or 
osteoclast progenitor cells tobecome active osteoclasts in a dose-dependent manner 
37
. It 
is a chemokines crucial for Immune responses during infection and inflammation, being 
produced by macrophages after they are stimulated with bacterial endotoxins. It acti-
vates human granulocytes (neutrophils, eosinophils and basophils) which can lead to 
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acute neutrophilic inflammation37. It also induce the synthesis and release of other pro-
inflammatory cytokines, such as interleukin 1 (IL-1), IL-6 and TNF-
α, from fibroblasts and macrophages  38. MIP-1α has been detected at higher levels in 
saliva in a longitudinal study of adolescents who had aggressive periodontitis compared 
with controls 
24 
. However, MIP-1α does not seem to be elevated in the saliva of chronic 
adult-periodontitis patients 
29
 
 
Molecules of connective tissue destruction 
The destruction of connective tissue matrix is responsible for the pathogenesis of chron-
ic inflammatory states, such as periodontitis 
17
. Degradation of the matrix is initiated 
extra- and pericellularly by proteinases produced locally at the inflammatory site and 
balanced by inhibitors of proteinases. The level of balance/imbalance is thought to de-
termine the progression rate of chronic periodontitis. 
 
Matrix metalloproteinase-8 (MMP-8)  - Matrix metalloproteinases (MMPs) 
are zinc-dependent proteolytic enzymes that degrade the extracellular collagen matrix 
and are involved in the healing of injured tissue
39
. They are predominantly derived from 
polymorphonuclear leukocytes. Thus, their expression levels are low in noninflamed 
periodontium but are significantly higher at sites of periodontal inflammation, being 
related to the migration of polymorpho-nuclear leukocytes into diseased sites. 
39
  MMP-
8 is the main destructive metalloproteinase (MMP), involved in the pathogenesis of 
periodontitis and is found in high amounts in gum biopsy and in oral fluids .40 . MMP-8 
has the unique ability to break down type I and III collagens, which are the major 
collagen species within the periodontium. MMP-8 also acts in a protective/anti-
inflammatory manner, inhibiting alveolar bone loss in a murine model of bacterium-
induced periodontal disease.
41
. MMP-8 has been readily detected in the saliva of 
patients experiencing periodontal disease
424344
. In fact salivary MMP-8 levels are 
elevated in patients with aggressive periodontitis compared with healthy controls
25
. 
Elevated salivary MMP-8 levels correlated highly with clinical measures consistent 
with the features of periodontal disease, and elevated levels of MMP-8 were 
significantly associated with an increased risk for clinical parameters of periodontal 
disease. It was also demonstrated that both MMP-8 and MMP-9 levels were detectable 
in the saliva of patients with chronic periodontitis and levels of MMP-8, but not MMP-
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9, decreased after conventional therapy (i.e., scaling and root planning) as well as after 
doxy cycline therapy 
25
 So, it suggests that MMP-8 has an important role in monitoring 
of periodontitis development. 
Aminotransferases - Aminotransferases (aspartate aminotransferase [AST] and 
alanine aminotransferase [ALT]) are enzymes relevant to periodontal disease diagno-
sis
46
. Both are cytoplasmic enzymes important for the metabolism of various amino 
acids and serve as diagnostic analytes of cellular injury in clinical chemistry
4546
. AST 
and ALT catalyze amino-transfer or transamination, during the carabolic and anabolic 
pathways of aminoacids. They are ubiquitous components of saliva and are detected in 
periodontal tissue, GCF 
46
, the enamel pellicle 
47
 and saliva. Fibroblasts from the perio-
dontal ligament produce significantly lower levels of aminotransferases than gingival 
epithelial cells. In one study of patients with periodontal disease, salivary AST activity 
was significantly increased (by five times) compared with controls, whereas salivary 
ALT activity was not significantly altered in patients with periodontal disease
31
. In an-
other report, salivary AST levels were significantly higher in a group of patients who 
had more severe periodontal disease than controls 
48
. In addition, gingival bleeding and 
suppuration were observed in 20% of individuals with salivary AST concentrations 
three-times higher than the median of the controls
48
. Similarly, in a larger patient co-
hort, AST levels significantly increased with increasing severity of periodontitis, 
whereas ALT levels increased, but not to a significant level, above the healthy controls 
35
 It has also been demonstrated that salivary levels of AST and ALT in patients with 
periodontitis decrease significantly after scaling 
49
. These findings suggest that perio-
dontal destruction, gingival bleeding and suppuration are related to higher AST levels 
and possibly also to ALT levels in saliva, and confirm   earlier studies that demonstrate 
similar increased levels of AST in crevicular fluid at sites of     periodontitis 
46
. Thus, 
salivary markers of cell injury, such as AST, appear to be useful for assessing periodon-
tal disease. 
 
Tissue inhibitors of metalloproteinases (TIMPs) -  The activities of MMPs in 
body tissues, such as the periodontium, are regulated at one level by tissue inhibitors of 
metalloproteinases (TIMPs)
50
. This well-studied family of inhibitors consists of four 
members (TIMPs 1–4). TIMP-1, -2 and -4 are secreted extracellular proteins and TIMP-
3 is bound to the extracellular matrix. All can inhibit MMPs. TIMPs can also exert other 
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functions including, but not limited to, MMP transportation and stabilization, MMP 
focalization to the cell surface, inhibition of angiogenesis and promotion of bone-
resorbing activity
50
. The most common inhibitor, TIMP-1, is secreted by the regional 
cells of the periodontium (fibro-blasts, keratinocytes and endothelial cells) and by the 
migratory cells of the inflammatory infiltrate (monocytes/macrophages)
50
. Under natu-
ral conditions, inhibitors of MMPs are required for the normal physiological remodeling 
of connective tissue. The imbalance between MMPs and tissue inhibitors of matrix met-
alloproteinases (TIMPs) is considered to trigger the degradation of extracellular matrix, 
basement membrane, and alveolar bone, and thus to initiate periodontal disease50. An 
increase in MMP and a decrease in TIMP levels initiate collagen degradation from con-
nective tissue and alveolar bone. Lower levels of TIMPs have been found in the saliva 
of patients with chronic periodontitis
50
  . Doxycycline treatment, combined with con-
ventional periodontal treatment, increases salivary TIMP-1 concentration in these pa-
tients 
50
 
 
Bone remodeling biomarkers 
Osteoprotegerin (OPG)/ nuclear factor kappa B (RANKL)  - The osteopro-
tegerin is a member of the family of the tumor necrosis factor(TNF) receptor, which is 
expressed by osteoblasts51. The function of OPG is to reduce the interaction between the 
ligand receptor activator of nuclear factor kappa B (RANKL) and receptor activator of 
nuclear factor kappa B (RANK) on the cell surface. It competes with RANKL for bind-
ing to RANK,, competitively inhibiting osteoclast differentiation and activity51.  The 
balance between receptor activator of NF-κB ligand (RANKL) and osteoprotegerin is 
critical to bone remodeling 
52
. Changes in this balance are observed in periodontal dis-
ease 
52
. In this context, salivary RANKL levels are significantly higher in untreated non-
smoking, periodontitis patients than those who received maintenance therapy
52
.  
 
Alkaline phosphatase Alkaline phosphatase (ALP) is a nonspecific hydrolase 
enzyme present in all bodily tissues, but is particularly abundant in the liver, kidney and 
bone
53
. It is associated with the calcification process, and elevated ALP levels are com-
mensurate with active bone remodeling
53
. Activity levels of ALP were significantly 
higher in pregnant women with periodontitis than those with gingivitis or a healthy per-
iodontium 
53
. In another study, it was observed that salivary ALP activity was also sig-
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nificantly higher (five times) in saliva from patients with periodontal disease than con-
trols 
54
. 
 
Aspects that may affect salivary biomarkers 
concentration 
Salivary diagnostics face many challenges before the entry into mainstream clin-
ical care is achieved. Proteins, inhibitors and enzymes, known to be present in saliva, 
may obscure or destroy antigenic determinants needed for immunoassays, and many 
inflammatory markers and proteases are at elevated levels in patients who experience 
gingivitis and periodontitis  
Moreover, when investigating periodontitis risks smoking status and obesity 
must be taken into account 55 
Smoking is a strong risk factor for periodontal disease in adults56. Tobacco 
smoking affects the immune system and impairs the host defenses by inhibiting 
granulocyte function56 Smoking seems to also affect the salivary inflammatory 
biomarkers levels. For example Mantyla et al. reported that the mean MMP-8 
concentrations in adults who smoke were lower than in non-smokers57. Obesity is 
known to affect host immunity58. Increased abdominal adiposity is a key factor. It has 
been reported that obese, hypertensive rats are more likely to have periodontitis than 
normal rats; the periodontal vessels of those rats show intimal thickening, indicating 
diminished blood flow58. Plasminogen activator inhibitor-1 (PAI-1), whose gene 
expression is enhanced in visceral fat, induces agglutionation of blood and raises th risk 
of ischemic vascular disease58. Therefore, PAI-1 may also decrease blood flow in the 
periodontum of obese subjects to promote periodontitis, PAI-1 system plays an 
important role in gingival inflammation58. 
The orthodontic treatment must also be taken into consideration. It is a treatment 
based on the controlled movement of the teeth by applying mechanical forces59. It 
occurs through the development of areas of stress and strain in the periodontal ligament, 
resulting in areas of apposition and bone resorption. This (controlled)  inflammatory 
mechanism  is dependent on the specific release of biochemical mediators associated 
with chronic inflammation and osteoclast stimulation, such as IL-1β and TNFα 59.60 In 
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vitro studies showed that during movement of the tooth there is a sharp increase in the 
concentrations of thse molecules.Furthermore, some authors also found significant 
changes in biochemical composition of crevicular fluid in vivo6162. Systemic diseases 
can also influence molecules appearing in saliva. Infectious disease states, such as HIV 
infection, are known to be associated with altered salivary MMP and TIMP levels 
63
 and 
serum MIP-1α levels are elevated in multiple myeloma and other lytic bone disorders63 
potentially confounding its utility in salivary diagnosis of periodontal disease Cyclic 
changes in salivary ALP levels have been associated with the menstrual cycle  and oral 
lesions 
64
, and periodontal therapy has resulted in altered levels of inflammatory 
cytokines and TIMPs in saliva
65
. Additional confounders include low flow saliva rates 
due to dehydration, drug administration or systemic diseases that can affect/limit saliva 
collection, and day-to-day variations
65
. All these factors must be rigorously considered 
before saliva gains real-world application.
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Discussion 
The traditional diagnostic parameters for periodontitis are implemented owing to 
their ease of use, relative noninvasiveness and reliability. However, there are several 
limitations to this diagnostic approach. It is needed a high trained clinician with assis-
tance to record the findings. The collection of the diagnostic information includes the 
use of expensive radiographic equipment that makes the procedure time and labor-
intensive as well as costly to the consumer. These diagnostic parameters are excellent at 
determining a past history of disease but provide limited ability to determine the ongo-
ing disease unless standardized longitudinal measures are obtained. A significant 
amount of damage must occur before these diagnostic parameters are able to assess the 
amount or severity of disease. Another limitation is the interexaminers differences when 
measuring parameters, due to the subjectivity of some of the analysis.In addition, there 
are some factors that may influence the precision of periodontal probing which are re-
lated to design and handling facility of the instrument and health of the gingival tissues, 
as well as experience of the clinician. Thus, periodontal probing is an imprecise tech-
nique with several potential sources of error. Furthermore, it has been clearly shown that 
extrinsic factors, such as smoking, can reduce the bleeding response to the periodontal 
probing 66. As well, the fact that BOP could appear either from a deep periodontal tissue 
inflammation or to a superficial one could have important implications that should not 
be underestimated. Inherent difficulties in accurately assessing attachment levels in-
clude inflammation, which causes coronal displacement of the gingival margin without 
a concomitant migration of the dento-gingival epithelium to a level apical to the cement 
enamel junction, and recessions, in which an obvious loss of attachment has occurred, 
but there is no increase in probing depth20. 
Oral fluids have been investigated as an alternative diagnostic approach. Initial-
ly, the focus was on the oral fluids emanating from individual teeth
15
. This fluid, known 
as GCF, is an inflammatory exudate collected by dentists on filter paper strips. Its use 
has several diagnostic advantages as contributing inflammatory mediators and tissue-
destructive molecules associated with periodontitis appear, and can be detected, in GCF. 
However, GCF analyses are time consuming by requiring multiple sampling of individ-
ual tooth sites onto filter paper strips. The procedure is labor intensive and somewhat 
technically demanding, requiring equipment for calibrating and measuring fluid vol-
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umes. Finally, the assessment of analytes is expensive since each sample must be evalu-
ated individually and the required assays are laboratory based and generally cannot be 
done chairside. In addition, GCF analyses involve miniscule amounts of fluid, often 
approximately 1 μl, which has an impact on laboratory analysis, and can be contaminat-
ed with blood, saliva or plaque. 
The advantage of using saliva as a study specimen is that it can be easily and 
non-invasively collected and the collection does not require specially trained dental 
nurses or assistants. However, one important disadvantage of using saliva for periodon-
tal disease diagnosis is that it fails to detect the exact site of active disease. Furthermore, 
variations in salivary flow rate, use of antimicrobial medications, orthodontic treatment, 
smoking habits or obesity can have an impact on salivary analysis. Indeed, one prereq-
uisite for a good periodontal disease marker is its function at population level, for ex-
ample independently of smoking habits or of other modifiers. Knowledge of levels of 
specific salivary biomarkers can, in turn, provide patients and healthcare practitioners 
with the ability to determine whether a disease is present, whether initiation of treatment 
is needed or if treatment has been successful. 
It was demonstrated that the concentration of IL-1β12 26 28 29 30, IL-630 and TNF-α 
29 30 36
, MMP-8 
44 50
, AST 
35 54 
OPG 
12 40
 and alkaline phosphatase 
53 54
 were elevated in 
individuals  with periodontal disease, compared to healthy controls, ALT 
35 54
 levels 
were elevated but less well characterized than AST, TIMPs 
50
 were decreased, MIP1α 29 
levels were elevated in aggressive periodontitis,  while RANKL 
3640 
levels were 
indeterminate (this may be due to the difficulty to detect soluble RANKL in saliva, 
because it may be bound to OPG or degraded by salivary proteases). 
12 36 40 
It is generally considered that the combined use of biomarkers increases the sen-
sitivity and specificity for obtaining accurate diagnostic information. An example of this 
comes from studies where diagnostic thresholds were established using elevated sali-
vary levels of MMP-8 and IL-1β. Individually, these biomarkers are significantly asso-
ciated with increased risk for periodontal disease
36
. However, their use in conjunction 
(diagnostic panels) demonstrates that the risk for periodontal disease is much greater 
when elevated salivary levels of MMP-8 and IL-1β are greater than two standard devia-
tions above the mean of healthy control values
36
. 
Salivary proteins as biomarkers for periodontal disease  2012
 
Faculdade de Medicina Dentária da Universidade do Porto  21 
However, an important point is that gingival inflammation itself can affect IL-1β 
secretion and consequently, its concentration in saliva, regardless of the individual 
subject’s pocket depth5. 
Having an agreement on MMP-8 as a biomarker of periodontitis is limited 
mainly due to differences in applied methods
41
. Detection of both latent (precursor) and 
active forms of MMP-8 (both free and complex) in oral fluids may not necessarily 
correlate with periodontal disease progression, as the active form is associated with 
periodontitis, while the latent form is associated with gingivitis
41
 
67
. A time-resolved 
immunofluorometric assay (IFMA) has been introduced to detect active MMP-8 
41
. The 
IFMA method differs from the other immunodetection methods by its unique antibody, 
which detects both PMN- and fibroblast type MMP-8 isotypes, and especially their 
active forms 
41
. 
The field of salivary diagnostics is rather new, but a growing number of reports 
have been published on the topic. Its emerging status is evident, in that many analytes 
have been investigated by a limited number of scientists; many only in cross-sectional 
study designs. Accordingly, a few promising analytes have been identified
11
 
41
. Before 
salivary diagnostics becomes established in clinical practice, biomarker discovery needs 
greater development and validation, especially with respect to which salivary 
biomarkers best correlate with periodontal disease. 
Targeted approaches that identify key biomarkers linked to distinct biological 
phases of disease are needed to generate the panels required to provide the sensitivity 
and specificity needed for accurate and reproducible disease diagnosis. Identifying key 
molecules that appear in saliva during the processes of inflammation, connective tissue 
destruction and bone remodeling are critical to the field of salivary diagnosis and perio-
dontal disease
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Conclusion 
Salivary diagnostic is an emerging field, that reveals a high clinical potential. 
Since levels of salivary analytes have the potential to reflect current disease activity and 
severity, salivary biomarkers derived from serum, gingival crevicular fluid and mucosal 
transudate can be useful for planning further treatment or/and evaluating if the current 
treatment is being effective.  
Relevant clinical markers associated with specific biological phases of periodon-
tal disease markers of inflammation, connective tissue destruction and bone remodeling 
associated with periodontitis appear in saliva. Specificity demands will likely require 
use of biomolecules from all three biological phases to `rule in' periodontitis and ex-
clude other inflammatory diseases of the oral cavity. Smoking and obesity may affect 
the usefulness of salivary biomarker analyses and must always be considered, an even-
tual orthodontic treatment may further complicate the diagnosis reliability. Other factors 
such as systemic diseases, salivary flow rate, use of antimicrobial medications may also 
influence on results.  
In the near future, biomarker panels are likely to gain the specificity needed for 
the utility of saliva as a true diagnostic fluid. However, this will only be achieved once 
the proper combination of markers are validated in longitudinal studies and their relia-
bility confirmed with respect to cyclical day-to-day variations and potential confounders  
Furthermore studies are needed that sample patients at regular intervals in order 
to capture analyte profiles seen during different phases of active disease. 
This approach will hopefully allow more individualized treatment to be provided 
before significant tissue destruction occurs.
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